RxDoctor Payments DataLook up a doctor →

Piotr Kulikowski, MD

Internal Medicine · Saint Louis, MONPI 1053388678

Payments from drug & device makers

$28,795in general payments, 2019–2025

Across 727 payments — averaging $39.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optos, Inc.$13K
  • AstraZeneca$3K
  • Lilly USA, LLC$2K
  • Otsuka America Pharmaceutical, Inc.$854
  • Axsome Therapeutics, Inc.$769
  • Amgen$699
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Optos, Inc.3$12,937
AstraZeneca75$2,593
Lilly USA, LLC88$1,547
Otsuka America Pharmaceutical, Inc.37$854
Axsome Therapeutics, Inc.16$769
Amgen37$699
Astellas Pharma US Inc29$696
Takeda Pharmaceuticals U.S.A., Inc.38$649
Novartis41$632
Teva Pharmaceuticals USA, Inc.8$587
Bayer27$562
Novo Nordisk37$529
Vanda Pharmaceuticals Inc.5$491
AbbVie(2 entities)21$431
Pfizer27$427
Eisai Inc.21$326
Lundbeck LLC13$293
Biogen15$262
UCB, Inc.17$254
Phathom Pharmaceuticals, Inc.8$230
Merck13$228
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$226
Gilead16$213
Aimmune Therapeutics, Inc.9$209
Ardelyx, Inc.5$179
Johnson & Johnson11$169
Boehringer Ingelheim9$157
Kowa Pharmaceuticals America, Inc.10$153
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$116
Nestle Healthcare Nutrition Inc.5$102
Amarin Pharma, Inc.7$95
Sanofi-aventis U.S. LLC4$91
Exact Sciences4$83
Abbott4$77
Boston Scientific3$77
Sunovion Pharmaceuticals Inc.4$73
Biohaven Pharmaceuticals, Inc.4$58
Fresenius USA Marketing, Inc.3$55
E.r. Squibb & Sons, L.L.C.3$54
Scilex Pharmaceuticals Inc.3$50
GSK3$48
Sumitomo Pharma America, Inc.2$47
GE HealthCare2$46
Harmony Biosciences LLC1$44
Paratek Pharmaceuticals, Inc.2$41
OPKO Pharmaceuticals, LLC2$33
Vifor Pharma, Inc.2$31
Medtronic1$30
Edwards Lifesciences1$30
Convatec Inc.1$25
Arbor Pharmaceuticals, Inc.2$24
Calliditas Therapeutics US Inc.1$23
Acadia Pharmaceuticals Inc1$21
Avanir Pharmaceuticals, Inc.1$21
Daiichi Sankyo Inc.1$19
Outset Medical Inc1$19
Radius Health, Inc.1$18
Inspire Medical Systems, Inc.1$17
Collegium Pharmaceutical, Inc.1$13
Hikma Pharmaceuticals USA1$12

How this compares

$28,795 in reported general payments places this provider in the 95th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri →

Medicare billing

Part B allowed, 2024
$331,753
Medicare patients
462
Services billed
3,482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →